Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Cancer Pain 1

Interventions

Cyclophosphamide 69fludarabine phosphate 63Busulfan 45Peripheral Blood Stem Cell Transplantation 42Tacrolimus 40Mycophenolic Acid 37Filgrastim 35Antilymphocyte Serum 35fludarabine 31Cyclosporine 30Radiotherapy 29Melphalan 29Whole-Body Irradiation 27Methotrexate 24Etoposide 20Cord Blood Stem Cell Transplantation 18Biopsy 18Methylprednisolone 16Specimen Handling 15Rituximab 14Magnetic Resonance Spectroscopy 13Alemtuzumab 12Stem Cell Transplantation 11Granulocyte Colony-Stimulating Factor 11Cytarabine 11sargramostim 9Sirolimus 9Prednisone 9Dexamethasone 9plerixafor 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Sodium Bicarbonate × Plasma cell × Clear all
NCT01846429 2015-06-04

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cancer Pain, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡